Sensitivity of the PCP receptor and the dopamine transporter to ligands bearing multiple asymmetric centres

[1]  J. Vignon,et al.  PCP receptor and dopamine uptake sites are discriminated by chiral TCP and BTCP derivatives of opposite configuration , 1995 .

[2]  J. Cadet,et al.  Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes. , 1994, The Journal of pharmacology and experimental therapeutics.

[3]  A. Privat,et al.  Homochiral structures derived from 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) are potent non-competitive antagonists of glutamate at NMDA receptor sites , 1994 .

[4]  B. Scatton.  Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases. , 1994, Life sciences.

[5]  A. Privat,et al.  Thienylphencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury. , 1993, Journal of neurosurgery.

[6]  J. Costentin,et al.  Arylcyclohexylamines derived from BTCP are potent indirect catecholamine agonists , 1993 .

[7]  Z. Wiesenfeld‐Hallin,et al.  Protective effect of the NMDA antagonist MK-801 on photochemically induced spinal lesions in the rat , 1992, Experimental Neurology.

[8]  N. Raz,et al.  Age-related regional differences in cerebellar vermis observed in vivo. , 1992, Archives of neurology.

[9]  C. George,et al.  Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine. , 1991, Journal of medicinal chemistry.

[10]  A. Privat,et al.  Localization of dopamine carriers by BTCP, a dopamine uptake inhibitor, on nigral cells cultured in vitro , 1991, Brain Research.

[11]  G. Albers,et al.  N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia? , 1989, Annals of neurology.

[12]  J. Vignon,et al.  Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs , 1989, Pharmacology Biochemistry and Behavior.

[13]  G. Rondouin,et al.  Non-competitive antagonists of N-methyl-d-aspartate receptors protect cortical and hippocampal cell cultures against glutamate neurotoxicity , 1988, Neuroscience Letters.

[14]  K. Rice,et al.  Synthesis, pharmacological action, and receptor binding affinity of the enantiomeric 1-(1-phenyl-3-methylcyclohexyl)piperidines. , 1988, Journal of medicinal chemistry.

[15]  E. Domino,et al.  Sigma and Phencyclidine: Like Compounds As Molecular Probes in Biology , 1988 .

[16]  J. Vignon,et al.  [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex. , 1988, European journal of pharmacology.

[17]  K. Rice,et al.  An efficient synthesis of optically pure (S)-(-)-3-methylcyclohexanone , 1987 .

[18]  A. Privat,et al.  [3H]Thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localization by autoradiographic and biochemical techniques , 1986, Brain Research.

[19]  F. Cartledge,et al.  A convenient synthetic route to methylated silacyclohexanes , 1986 .

[20]  M. Lazdunski,et al.  [3H]TCP: a new tool with high affinity for the PCP receptor in rat brain , 1983, Brain Research.

[21]  J. Kamenka,et al.  Conformational determination of phencyclidine derivatives for a structure activity correlation , 1979 .